Genetic Technologies provides U.S. patent re-examination update Genetic Technologies announced that the USPTO has now issued an action reaffirming the validity of certain claims contained in the Company's U.S. Patent No. 5,612,179 directed to non-coding DNA. As announced by the Company on July 9, 2012, Genetic Technologies had received formal notification from the USPTO that it had received and granted a request for ex parte re-examination of claims 1-18 and 26-32 of the '179 patent based upon a submission by Merial of Duluth, Georgia. Merial is currently a defendant in an action originally brought by the company in Colorado, USA for infringement of the '179 patent. That action currently is pending in Delaware Federal District Court.